$4.17
-0.11-2.57%
Last update: Nov 10, 12:07 PM
Nu Skin Enterprises Inc
NUSNYSE
Nu Skin Enterprises fell 56.6% from $9.87 to $4.28, behind the S&P 500's +10.5%. Its worst day was Feb 13 (−18.1%), and its low came Nov 6 at $4.10.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Nu Skin Enterprises closed at its highest level of the year, 16.9% above where the year started.
+1.8% · S&P 500 −0.1%
EPS of $0.29 missed the $0.30 estimate on $370.3M revenue (est. $382.7M); FY revenue guidance of $1.4B–$1.5B against the $1.5B consensus.
Story events cover the past 12 months · Times ET
−18.1%, the year's worst day · S&P 500 +0.1%
EPS of $0.14 missed the $0.15 estimate on $320.6M revenue (est. $329.7M); Q2 revenue guidance of $330.0M–$360.0M against the $361.0M consensus.
+2.0% · S&P 500 +0.8%
EPS of $0.20 beat the $0.20 estimate on $320.1M revenue (est. $345.2M); FY revenue guidance of $1.3B–$1.4B against the $1.4B consensus.
−5.4% · S&P 500 −0.3%
EPS of $0.10 missed the $0.21 estimate on $311.0M revenue (est. $328.7M); FY revenue guidance of $1.3B–$1.3B against the $1.3B consensus.
−9.5% · S&P 500 +0.3%
Where it ended: a close of $4.28 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.18, revenue est. $323.9M).
Nothing in the past 12 months.
All NUS analyst actionsReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NUS and SPY from Benzinga historical bars. Not investment advice.
